Isincomo Esisha Sokuvikela Abantu Abanomdlavuza ku-COVID-19

Namuhla, i-National Comprehensive Cancer Network® (NCCN®) ishicilele izibuyekezo ezibalulekile zezincomo zokuvumelana kochwepheshe mayelana nokugoma kanye ne-pre-exposure prophylaxis ye-COVID-19 kubantu abanomdlavuza. IKomidi Lokweluleka le-NCCN Lokugomela i-COVID-19 kanye ne-Pre-exposure Prophylaxis lihlangana njalo ukuze libuyekeze lonke ucwaningo olutholakalayo futhi linikeze izindlela ezingcono kakhulu ezisekelwe ebufakazini zokugcina abantu abanomdlavuza bephephile ngangokunokwenzeka phakathi nobhadane lwe-COVID-19. Umhlahlandlela obuyekeziwe—otholakala ku-NCCN.org/covid-19—uhlanganisa ulwazi lokuvimbela ukusetshenziswa kwamasosha omzimba womuntu ngaphezu kwalezi zihloko ezilandelayo:       

• Iziguli ezinomdlavuza kufanele zigonywe ngokugcwele, okuhlanganisa imithamo yesithathu kanye/noma noma yiziphi izikhuthazi ezigunyaziwe;

• Kukhona ukuthanda kakhulu imigomo ye-mRNA;

• Ukugoma kufanele kubambezeleke okungenani izinyanga ezi-3 ngemva kokufakelwa kwe-hematopoietic cell (HCT) noma ukwelashwa kwamaselula okunjiniyela (isb. i-chimeric antigen receptor [CAR] T-cells) ukuze kukhuliswe ukusebenza kahle komgomo. Ukubambezeleka kokugoma ezigulini ezinomdlavuza kufanele futhi kufake lezo ezinconyelwe umphakathi jikelele (isb. ukuchayeka kwakamuva ku-COVID-19, ukwelashwa kwe-monoclonal Ab kwakamuva);

• Ukugonywa okuphelele nakho kuyanconywa kubanakekeli, abasekhaya/abaseduze, kanye nomphakathi jikelele;

• Ikomidi lisekela ngokuqinile iziyalezo zokugoma zabasebenzi bezempilo.

I-Food and Drug Administration (FDA) ikhiphe ukugunyazwa kokusetshenziswa okuphuthumayo kwenhlanganisela ye-monoclonal antibody ye-tixagevimab kanye ne-cilgavimab yokuvikela ukuchayeka ku-COVID-19 kubantu abadala nasezinganeni eziqala eminyakeni eyi-12 (isisindo okungenani esingama-40 kg) abanesilinganiso esimaphakathi. ekulimaleni okukhulu kwamasosha omzimba futhi kungenzeka ungaphenduli ekugomeni. Iziguli ezinomdlavuza wegazi (kuhlanganise nalezo ezithola ukufakelwa ama-stem cell noma ukwelashwa ngamaselula okunjiniyela) kungenzeka zibe nezimpendulo ezinganele ekugonyweni kwe-COVID-19 futhi zisengozini enkulu yezinkinga ezinkulu ze-COVID-19. Ikomidi lithi kunengqondo ukubeka phambili lezi ziguli nge-tixagevimab kanye ne-cilgavimab ngaphambi kweziguli ezinomdlavuza oqinile wesimila uma kwenzeka ukutholakala okulinganiselwe.

Ikomidi liphinde lisekele izincomo ezivela kuCenters for Disease Control (CDC), American Society of Transplantation and Cellular Therapy (ASTCT), kanye ne-American Society of Hematology (ASH) ukuthi iziguli ezazigonyiwe ngaphambilini eziqeda ukufakelwa kwe-stem cell noma ukwelashwa kwamaselula okunjiniyela kufanele zithole ukwelashwa. phinda uchungechunge lokugoma oluqala ezinyangeni ezintathu emva kokwelashwa.

IKomidi Lokweluleka le-NCCN mayelana Nokugonywa kwe-COVID-19 kanye ne-Pre-exposure Prophylaxis lakhiwe odokotela abahola imikhakha eminingi abavela kuzo zonke izikhungo ezingamalungu e-NCCN, abanobuchwepheshe obukhethekile ezifweni ezithathelwanayo, ukuthuthukiswa kokugoma nokulethwa, ukuphathwa komdlavuza, kanye nezimiso zezokwelapha. I-NCCN izoqhubeka nokubuyekeza izincomo ukuze ivumelane nezimo ezishintshayo, kuhlanganise nobufakazi obukhulayo.

Zonke izincomo ze-NCCN zokunakekelwa komdlavuza phakathi nobhubhane zingatholakala ku-NCCN.org/covid-19. Umhlahlandlela wesiguli kanye nomnakekeli wokugoma uyatholakala futhi ku-NCCN.org/patientguidelines.